I spent time this morning conversing about when/if Christina Aguilera’s career peaked on one of my Britney groups and discussing macro-economical and approval influences on the peak of pharmaceutical stocks on an investment group.

Sadly, the first conversation was more fact-based and well-reasoned than the latter.